|4Aug 5, 6:11 PM ET

Dubin Michael F 4

4 · Virpax Pharmaceuticals, Inc. · Filed Aug 5, 2021

Insider Transaction Report

Form 4
Period: 2021-07-26
Transactions
  • Award

    Stock Option (right to buy)

    2021-07-26+20,22520,225 total
    Exercise: $4.32From: 2022-07-26Exp: 2031-07-26Common Stock, par value $0.00001 per share (20,225 underlying)

Documents

1 file
  • 4
    virpax_fm4jul262021.xmlPrimary